IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MEOLA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.222
NA - Nord America 11.568
AS - Asia 4.962
SA - Sud America 292
OC - Oceania 89
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
Totale 31.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.133
GB - Regno Unito 5.004
IT - Italia 3.077
CN - Cina 2.016
DE - Germania 1.412
SE - Svezia 1.079
SG - Singapore 918
RU - Federazione Russa 754
UA - Ucraina 556
TR - Turchia 518
FR - Francia 494
IE - Irlanda 455
KR - Corea 437
IN - India 400
CA - Canada 386
NL - Olanda 335
FI - Finlandia 322
EU - Europa 304
JP - Giappone 184
CO - Colombia 169
ES - Italia 142
HK - Hong Kong 121
ID - Indonesia 118
GR - Grecia 96
BE - Belgio 93
VN - Vietnam 86
PL - Polonia 79
AU - Australia 75
BR - Brasile 71
CH - Svizzera 57
DK - Danimarca 50
TW - Taiwan 41
MX - Messico 40
CZ - Repubblica Ceca 39
RO - Romania 39
PT - Portogallo 37
PH - Filippine 26
NO - Norvegia 23
EG - Egitto 21
MY - Malesia 21
HU - Ungheria 19
IL - Israele 16
RS - Serbia 16
CL - Cile 15
IR - Iran 15
AR - Argentina 14
NZ - Nuova Zelanda 13
BG - Bulgaria 10
AT - Austria 9
IQ - Iraq 9
PE - Perù 9
HR - Croazia 7
SI - Slovenia 7
TH - Thailandia 7
BJ - Benin 6
UZ - Uzbekistan 6
BD - Bangladesh 5
CR - Costa Rica 5
VE - Venezuela 5
DZ - Algeria 4
EC - Ecuador 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
LT - Lituania 3
PY - Paraguay 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
KZ - Kazakistan 2
QA - Qatar 2
SA - Arabia Saudita 2
SC - Seychelles 2
TN - Tunisia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 31.485
Salva come PNG Salva come JPEG
Città #
Southend 4.474
Chandler 1.120
Seattle 967
Milan 765
Fairfield 662
Princeton 656
Wilmington 613
Singapore 611
Ashburn 497
Beijing 469
Dublin 443
Woodbridge 395
Jacksonville 394
Dearborn 378
Mountain View 326
Ann Arbor 317
Redmond 307
Houston 304
Cambridge 263
Nanjing 248
Redwood City 225
Somerville 223
Serra 203
Toronto 200
Sakarya 190
Des Moines 162
Bengaluru 161
Andover 158
Bogotá 155
Rome 155
Boardman 148
Santa Clara 115
Pisa 110
Shanghai 107
Hamburg 94
Eitensheim 90
Hong Kong 90
Jinan 90
Frankfurt am Main 89
Athens 88
Shenyang 88
Nanchang 79
Berlin 76
Phoenix 75
Guangzhou 71
Helsinki 71
New York 69
Sunnyvale 68
Medford 60
London 57
Ottawa 56
Warsaw 56
Hebei 53
Jakarta 53
Hanover 51
Tokyo 51
Brussels 50
Changsha 50
San Diego 48
Vigo 48
Grafing 46
Bitonto 42
Turin 42
Los Angeles 41
Falls Church 38
Tianjin 38
Dong Ket 37
Jiaxing 35
Odernheim 35
Bologna 34
Seoul 34
Norwalk 33
Duncan 31
Chicago 30
Silver Spring 30
Taipei 30
Kent 27
Salt Lake City 27
Hangzhou 26
Kunming 25
Kiez 24
Rochester 24
Hefei 23
Roxbury 23
Changchun 22
Cornate D'adda 22
Ningbo 22
Boston 21
Cologno Al Serio 21
Fuzhou 21
Verona 21
Washington 21
Lanzhou 20
Nijmegen 20
Zhengzhou 20
Como 19
Florence 19
Wuhan 19
Liberty 18
Philadelphia 18
Totale 19.391
Salva come PNG Salva come JPEG
Nome #
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 568
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 475
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 432
Cerebral involvement in myotonic dystrophies 428
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 412
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 407
DM1, DM2 e paralisi periodiche : diagnosi e terapia 360
Andersen's syndrome : a distinct periodic paralysis 358
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 342
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 338
La canalopatia del cloro : diagnosi clinica differenziale 331
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 315
Treatment for periodic paralysis 288
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 248
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 246
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 244
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 240
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 239
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 227
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 225
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 216
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 215
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 212
Therapy in myotonic disorders and in muscle channelopathies 211
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 206
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 203
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 199
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 198
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 196
Oculopharyngeal muscular dystrophy in Italy. 185
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 182
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 181
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 180
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 180
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 179
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 177
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 176
Persistent autobiographical amnesia: a case report 175
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 174
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 166
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 166
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 164
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 161
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 161
Quantitative myotonia assessment: an experimental protocol 160
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 158
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 153
Migraine and patent foramen ovale: improvement after transcatheteral closure 152
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 152
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 151
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 151
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 148
A CASE OF MITOCHONDRIAL MYOPATHY, LACTIC-ACIDOSIS AND COMPLEX-I DEFICIENCY 146
[Expression of a defect in the respiratory chain in cultured human cells] 146
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 146
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 145
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 144
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 143
New mutations in SCN4A and their biophysical properties 142
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 139
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 139
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 138
Stable hybrid myotubes: a new model for studying re-expression of enzymatic activities in vitro 138
Miotonie e canalopatie 137
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 137
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 135
Lezioni di Traumatologia 135
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 134
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism 134
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 134
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 134
A multidisciplinary approach improves quality of life perception in patients with amyotrophic lateral sclerosis 133
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 133
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 132
Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5 132
Eight novel mutations in SPG4 gene in a large sample of patients with hereditary spastic paraplegia 131
Human skeletal muscle sodium channelopathies 129
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 128
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 128
Long-term effects of mexiletine on myotonia and on the cardiac conduction system of patients with myotonic dystrophy type 1 127
Dysregulated expression of micrornas in myotonic dystrophy type 1 127
RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1 127
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 127
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 127
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 125
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 124
Muscle surface mechanical and electrical activities in myotonic dystrophy 124
Advanced microscopic and histochemical techniques : diagnostic tools in the molecular era of myology 123
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 123
Apoptosis induced by proteasome inhibition in human myoblast cultures 121
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 121
Dysregulation of MicroRNA Expression in Myotonic Dystrophies 120
Manifesting carrier of x-linked Duchenne muscular dystrophy 120
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies 120
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 119
La qualità di vita nelle canalopatie scheletriche: miopatie benigne? 119
Muscleblind-like protein 1 nuclear sequestration and splicing pattern in myotonic dystrophy type 2 117
Muscle cramps, insuline resistance, acanthosis nigricans and acral hypertrphy sindrome : a potentially treatable condition 117
Effects of mexiletine on cardiac parameters, muscle strength and myotonia in myotonic dystrophy type 1 117
Colocalization of ribonuclear inclusions and MBNL1 foci with no impairment of muscle differentiation in DM2 116
Totale 18.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.876 0 0 0 0 304 513 491 264 502 496 175 131
2020/20213.654 126 281 254 175 376 264 363 221 344 202 814 234
2021/20223.278 268 126 211 121 238 283 293 135 312 371 276 644
2022/20233.956 568 331 369 463 463 697 141 242 366 73 150 93
2023/20242.362 99 189 148 98 509 177 85 150 75 221 246 365
2024/20251.724 280 612 143 441 248 0 0 0 0 0 0 0
Totale 33.205